To identify genetic susceptibility loci for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in the Chinese population, we carried out a genome-wide association study (GWAS) in 2,514 chronic HBV carriers (1,161 HCC cases and 1,353 controls) followed by a 2-stage validation among 6 independent populations of chronic HBV carriers (4,319 cases and 4,966 controls). The joint analyses showed that HCC risk was significantly associated with two independent loci: rs7574865 at STAT4, P meta = 2.48 × 10 −10 , odds ratio (OR) = 1.21; and rs9275319 at HLA-DQ, P meta = 2.72 × 10 −17 , OR = 1.49. The risk allele G at rs7574865 was significantly associated with lower mRNA levels of STAT4 in both the HCC tissues and nontumor tissues of 155 individuals with HBV-related HCC (P trend = 0.0008 and 0.0002, respectively). We also found significantly lower mRNA expression of STAT4 in HCC tumor tissues compared with paired adjacent nontumor tissues (P = 2.33 × 10 −14 ).
l e t t e r s
To identify genetic susceptibility loci for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in the Chinese population, we carried out a genome-wide association study (GWAS) in 2,514 chronic HBV carriers (1,161 HCC cases and 1,353 controls) followed by a 2-stage validation among 6 independent populations of chronic HBV carriers (4,319 cases and 4,966 controls). The joint analyses showed that HCC risk was significantly associated with two independent loci: rs7574865 at STAT4, P meta = 2.48 × 10 −10 , odds ratio (OR) = 1.21; and rs9275319 at HLA-DQ, P meta = 2.72 × 10 −17 , OR = 1.49. The risk allele G at rs7574865 was significantly associated with lower mRNA levels of STAT4 in both the HCC tissues and nontumor tissues of 155 individuals with HBV-related HCC (P trend = 0.0008 and 0.0002, respectively). We also found significantly lower mRNA expression of STAT4 in HCC tumor tissues compared with paired adjacent nontumor tissues (P = 2.33 × 10 −14 ).
HCC is one of the most common cancers and the third most common cause of cancer mortality worldwide 1 . Over 600,000 new HCC cases are diagnosed annually worldwide, among which ~55% are in China 2 . Chronic HBV infection seems to be the most important risk factor for HCC [1] [2] [3] . About 80% of individuals with HCC in China have a history of HBV infection 4 . Segregation analysis of familial HCC suggests interaction between HBV infection and a major genetic locus 5, 6 . However, specific genetic factors predisposing to HCC are largely unknown.
Recently, a GWAS of HBV-related HCC in a Chinese population led to the identification of an HCC susceptibility locus at 1p36. 22 (ref. 7) . However, considering the small sample size in the initial discovery stage of that GWAS (348 cases and 359 controls), many HCC risk loci with modest effects could have been missed 8, 9 . To search for additional susceptibility genes for HCC, we conducted a multistage GWAS in 11,799 Chinese chronic HBV carriers (Supplementary Table 1 ).
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma l e t t e r s
In the initial GWAS stage, we genotyped 733,202 SNPs across the genome in 2,689 chronic HBV carriers, including 1,212 HCC cases and 1,477 non-HCC controls from Qidong, China. After a quality control analysis and filtering steps (Online Methods), 568,280 SNPs in 1,161 cases and 1,353 controls were retained for further analyses. Principal-component analysis showed that cases and controls had similar distributions of the top two eigenvectors, suggesting a common genetic background for these study subjects ( Supplementary  Fig. 1 ). Consistent with this result, we found no evidence of population stratification, with genomic control inflation factor (λ GC ) = 1.01 (Supplementary Fig. 2 ). To further increase genome coverage, we carried out an imputation analysis to infer the genotypes of additional common SNPs on the basis of HapMap Han Chinese in Beijing, China (CHB) and Japanese in Tokyo, Japan (JPT) samples (release 24; Online Methods). For all 2,462,060 imputed SNPs, we adopted the same quality control and filtering criteria as for the genotyped SNPs, and 1,672,517 imputed SNPs were retained for the GWAS analysis. Finally, we carried out an association test of HCC risk with each of these genotyped and imputed SNPs under an allelic model using PLINK (v1.07). This analysis suggested that HCC is associated with SNPs in multiple regions throughout the genome, although these associations did not reach the genome-wide significance level (we adopted a threshold of P < 2.23 × 10 −8 for genome-wide significance, as we analyzed a total of 2.24 million genotyped and imputed SNPs in this study; Supplementary Fig. 3 ).
To confirm these suggestive associations, we selected 35 candidate SNPs for replication (Online Methods) in an independent casecontrol population of chronic HBV carriers (replication 1, 582 HCC cases and 672 controls from Suzhou, China; Supplementary Table 1) . Suggestive confirmation was found for two SNPs, rs7574865 (genotyped) at 2q32.2-2q32.3 and rs9275319 (imputed) at 6p21.3, at P < 0.05, with the same direction of association as observed in the initial GWAS stage (Supplementary Table 2) .
We then evaluated these 2 SNPs in 5 additional independent case-control populations of chronic HBV carriers, including 3,737 HCC cases and 4,294 controls (replication 2a, 1,016 cases and 924 controls from Shanghai; replication 2b, 967 cases and 1,031 controls from Nanjing, China; replication 2c, 790 cases and 616 controls from Beijing; replication 2d, 502 cases and 934 controls from Luoyang, China; and replication 2e, 462 cases and 789 controls from Fusui and Baise, China; Supplementary Table 1) . Both SNPs were significantly associated with HCC risk in these five populations at P meta < 1.0 × 10 −7 (Supplementary Table 3) .
When we performed a joint analysis of subjects from the GWAS stage and all subsequent replication cohorts, the statistical evidence for association between HCC risk and these two SNPs reached genome-wide significance at P meta = 1.66 × 10 −11 for rs7574865 and P meta = 8.65 × 10 -19 for rs9275319. The OR for HCC was 1.22 (95% confidence interval (CI) = 1.15-1.29) for allele G at rs7574865 and was 1.51 (95% CI = 1.38-1.66) for allele A at rs9275319. We found similar results when we adjusted for age and gender under an additive genetic model: P meta = 2.48 × 10 −10 and OR = 1.21 (95% CI = 1.14-1.28) for rs7574865; P meta = 2.72 × 10 −17 and OR = 1.49 (95% CI = 1.36-1.63) for rs9275319. We found no evidence for heterogeneity of OR for these two SNPs among these seven populations, with P het = 0.74 and 0.12, respectively ( Table 1 and Supplementary Table 4) .
The association of HCC risk with the rs7574865 SNP at 2q32.2-32.3 is previously unknown. This SNP is located in the third intron of STAT4, a transcription factor and a critical regulator of immune responses ( Supplementary Fig. 4) . STAT4 transmits signals from interleukin-12 and type I interferon (IFN-α or IFN-β) to induce IFN-γ production [10] [11] [12] . IFN-γ is a pleiotropic cytokine that has a crucial role in host defense 13 . Impaired activation of IFN-γ via STAT4 may reduce its antiviral and antitumor activities 14, 15 , whereas overexpression of IFN-γ may lead to the development of autoimmune diseases 16 . To examine the effect of genotypes at rs7574865 on STAT4 expression, we measured the mRNA levels of STAT4 in 155 individuals with HCC who are carriers of chronic HBV using quantitative RT-PCR. We found that subjects with the risk genotype GG at rs7574865 had the lowest mRNA level of STAT4, followed by subjects with the TG and TT genotypes, in both HCC tissues and nontumor tissues (P trend = 0.0008 and 0.0002, respectively) ( Fig. 1) . We also observed significantly lower mRNA expression of STAT4 in HCC tissues compared with paired adjacent nontumor tissues (P = 2.33 × 10 −14 ; Fig. 1 ). The latter npg finding is also supported by data from the OncoDB.HCC database (Supplementary Fig. 5) . Recently, multiple GWAS and candidate gene studies have reported associations of STAT4 variants, particularly the rs7574865 SNP, with various autoimmune diseases [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Notably, in contrast to our finding that the G allele at rs7574865 is associated with greater risk for HCC, this allele was associated with lower risk for autoimmune diseases (Supplementary Figs. 6 and 7 and Supplementary Table 5) . These results support the dual roles of STAT4 in autoimmune diseases and HBV-related HCC.
The association of HCC risk with rs9275319 at 6p21.3 was not reported in earlier GWASs of HCC. In addition to the strong statistical evidence, this association was supported by two other observations. First, this SNP is located between HLA-DQB1 and HLA-DQA2, which are biologically relevant in HCC (Supplementary Fig. 8 ). HLA-DQ proteins make up the human leukocyte antigen (HLA) class II complex, an α-β heterodimeric membrane glycoprotein that is expressed on the surface of antigen-presenting cells, such as macrophages, dendritic cells and B lymphocytes 27 . HLA-DQ genes have a central role in immune-mediated diseases, including liver diseases and cancer 28, 29 . SNPs in these genes have been implicated in risk for primary biliary cirrhosis 30, 31 , HBV 32 and hepatitis C virus (HCV)-related HCC 33 from several GWASs (Supplementary Table 6 ). SNPs in HLA-DQB1 were also associated with HBV and HCC risk in a candidate gene approach 34, 35 . Second, the observed association is likely not confounded by population stratification, a common concern for SNPs in the HLA region owing to highly variable allele frequencies for some SNPs among and within populations. The allele frequency of the rs9275319 SNP in controls was similar across all the populations in this study (0.87-0.90 for allele A) and was consistently lower than that in cases within each population (0.91-0.93 for allele A), except for the Guangxi population ( Table 1) .
To investigate whether the association of HCC risk with rs9275319 indirectly reflects association of established alleles in HLA-DQ genes, we analyzed HLA-DQB1 and HLA-DQA1 genotypes in 936 HBV carriers, including 478 HCC cases and 458 controls (a subset of the Qidong cohort samples used in the GWAS stage) using the sequence-based typing (SBT) method. Of the 33 alleles of the 2 HLA genes, 2 alleles (HLA-DQB1*0401 and HLA-DQA1*0303) were in moderate linkage disequilibrium (LD) with rs9275319 (r 2 = 0.48 and 0.47, respectively) and were significantly associated with HBV-related HCC risk (P = 4.51 × 10 −4 and 4.44 × 10 −4 , respectively). However, the strength of association was weaker than that of rs9275319 in this subset (P = 5.82 × 10 −6 ). Furthermore, when the rs9275319 SNP was included in the regression model, HLA-DQB1*0401 and HLA-DQA1*0303 were no longer significantly associated with HCC risk, suggesting that these two existing HLA alleles are probably not causal variants for HCC risk (Supplementary Table 7) . Additional studies are needed to dissect the causal association at this region.
Considering that HBV genotype (the major HBV genotypes are B and C in the Chinese population) and HBV viral load may affect the associations of HCC risk with the two SNPs, we measured the HBV genotype and HBV viral load in a subset of the Shanghai cohort and carried out association analyses of HCC risk with rs7574865 and rs9275319 by stratifying HBV genotype status or viral load. The ORs for HCC at each SNP were not significantly different between HBV genotype groups (P het = 0.77 for rs7574865 and 0.48 for rs9275319; Supplementary Table 8) . Similarly, the ORs for HCC at each SNP were not significantly different between the two HBV viral groups (HBV DNA < 2,000 and ≥ 2,000 copies/ml; P het = 0.54 for rs7574865 and 0.67 for rs9275319; Supplementary Table 8) .
To examine whether the two HCC risk-associated SNPs (rs7574865 at STAT4 and rs9275319 at HLA-DQ) are also associated with risk for chronic HBV infection, we compared 3,935 chronic HBV carriers without HCC (used in the replication 1 and 2 stages of our HCC study, except for the Nanjing population) with 4,585 healthy subjects who did not carry HBV (recruited in geographical areas corresponding to those of the HBV carriers; Supplementary Table 9 ). We found that the A allele at rs9275319 in HLA-DQ had consistently higher frequency in chronic HBV carriers in each population, and the overall evidence among all populations was significant (OR = 1.29, P meta = 3.54 × 10 −6 ; Supplementary Table 10 ). This result suggested that this SNP is also associated with susceptibility to chronic HBV infection. For rs7574865 in STAT4, we found similar results. There was a trend of higher frequency for the G allele in chronic HBV carriers in each population. However, the overall statistical evidence was weak (OR = 1.12, P meta = 0.003; Supplementary Table 10) .
A recent GWAS on HBV-related HCC in Chinese individuals reported a strong association with rs17401966 at 1p36. 22 (ref. 7) . In our study, we found no evidence of association between rs17401966 and risk for HCC in the first-stage samples of the GWAS (OR = 0.98, P = 0.79; Supplementary Table 11) . Similarly, a lack of association at this locus has been reported in a recent study of the eastern Chinese population (OR = 1.01, P = 0.92) 35 . Additional studies are needed to assess the association between this SNP and HCC risk 8, 9 .
Finally, we examined associations of HCC risk with SNPs that have been implicated in other HBV-related diseases and HCV-induced HCC. We found no evidence of association for any of these SNPs in our GWAS stage (Supplementary Table 11 ). Our study had >90% statistical power to detect associations for SNPs with risk allele frequency of >0.15 and with OR of >1.4 (Supplementary Table 12) .
In summary, we conducted a three-stage GWAS in seven case-control populations for HBV-related HCC among the Chinese population. We identified two previously unknown HCC 
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Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
